CG Oncology, Inc. Common stock ( CGON) - Stock Earnings
CGON Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -43.8 million USD | 1.7 million USD |
| 2025Q4 | -41.3 million USD | 2.3 million USD |
| 2026Q1 | -60.2 million USD | 1.1 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CGON Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -48.6 million USD | 204000 USD |
| 2024 | -88.0 million USD | 1.1 million USD |
| 2025 | -161.0 million USD | 4.0 million USD |
| 2026 Est. | — | — |
CGON
Price: $59.55
52 week price:
Earnings Per Share: -2.34 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.9 billion